Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration - PubMed (original) (raw)
Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration
Irina M Fedorova et al. Cell Mol Neurobiol. 2003 Jun.
Abstract
1. The potential neuroprotective actions of the A3 adenosine receptor (A3AR) were investigated using mice with functional deletions of the A3AR (A3AR-/-) in behavioral assessments of analgesia, locomotion, tests predictive of depression and anxiety, and the effects of mild hypoxia on cognition and neuronal survival. 2. Untreated A3AR-/- mice were tested in standard behavioral paradigms, including activity in the open field, performance in the hot-plate, tail-flick, tail-suspension, and swim tests, and in the elevated plus maze. In addition, mice were exposed repeatedly to a hypoxic environment containing carbon monoxide (CO). The cognitive effects of this treatment were assessed using the contextual fear conditioning test. After testing, the density of pyramidal neurons in the CA1, 2, and 3 subfields of the hippocampus was determined using standard histological and morphometric techniques. 3. A3AR-/- mice showed increased locomotion in the open field test, elevated plus maze (number of arm entries) and light/dark box (number of transitions). However, they spent more time immobile in two different tests of antidepressant activity (Swim and tail suspension tests). A3AR-/- mice also showed evidence of decreased nociception in the hotplate, but not tail-flick tests. Further, A3AR-/- mice were more vulnerable to hippocampal pyramidal neuron damage following episodes of carbon monoxide (CO)-induced hypoxia. One week after exposure to CO a moderate loss of pyramidal neurons was observed in all hippocampal subfields of both wild-type (A3AR+/+) and A3AR-/- mice. However, the extent of neuronal death in the CA2-3 subfields was less pronounced in A3AR+/+ than A3AR-/- mice. This neuronal loss was accompanied by a decline in cognitive function as determined using contextual fear conditioning. These histological and cognitive changes were reproduced in wild-type mice by repeatedly administering the A3AR-selective antagonist MRS 1523 (5-propyl-2-ethyl-4-propyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate 1 mg/kg i.p.). 4. These results indicate that pharmacologic or genetic suppression of A3AR function enhances some aspects of motor function and suppresses pain processing at supraspinal levels, while acting as a depressant in tests predictive of antidepressant action. Consistent with previous reports of the neuroprotective actions of A3AR agonists, A3AR-/- mice show an increase in neurodegeneration in response to repeated episodes of hypoxia.
Similar articles
- Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states.
Little JW, Ford A, Symons-Liguori AM, Chen Z, Janes K, Doyle T, Xie J, Luongo L, Tosh DK, Maione S, Bannister K, Dickenson AH, Vanderah TW, Porreca F, Jacobson KA, Salvemini D. Little JW, et al. Brain. 2015 Jan;138(Pt 1):28-35. doi: 10.1093/brain/awu330. Epub 2014 Nov 19. Brain. 2015. PMID: 25414036 Free PMC article. - Comprehensive behavioral phenotyping of a new Semaphorin 3 F mutant mouse.
Matsuda I, Shoji H, Yamasaki N, Miyakawa T, Aiba A. Matsuda I, et al. Mol Brain. 2016 Feb 9;9:15. doi: 10.1186/s13041-016-0196-4. Mol Brain. 2016. PMID: 26856818 Free PMC article. - The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists.
El Yacoubi M, Ledent C, Parmentier M, Costentin J, Vaugeois JM. El Yacoubi M, et al. Psychopharmacology (Berl). 2000 Feb;148(2):153-63. doi: 10.1007/s002130050037. Psychopharmacology (Berl). 2000. PMID: 10663430 - Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors.
Pugliese AM, Latini S, Corradetti R, Pedata F. Pugliese AM, et al. Br J Pharmacol. 2003 Sep;140(2):305-14. doi: 10.1038/sj.bjp.0705442. Epub 2003 Aug 11. Br J Pharmacol. 2003. PMID: 12970092 Free PMC article. - Behavioral and cognitive animal models in headache research.
Vuralli D, Wattiez AS, Russo AF, Bolay H. Vuralli D, et al. J Headache Pain. 2019 Jan 31;20(1):11. doi: 10.1186/s10194-019-0963-6. J Headache Pain. 2019. PMID: 30704400 Free PMC article. Review.
Cited by
- Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death.
Lauro C, Cipriani R, Catalano M, Trettel F, Chece G, Brusadin V, Antonilli L, van Rooijen N, Eusebi F, Fredholm BB, Limatola C. Lauro C, et al. Neuropsychopharmacology. 2010 Jun;35(7):1550-9. doi: 10.1038/npp.2010.26. Epub 2010 Mar 3. Neuropsychopharmacology. 2010. PMID: 20200508 Free PMC article. - Controlling murine and rat chronic pain through A3 adenosine receptor activation.
Chen Z, Janes K, Chen C, Doyle T, Bryant L, Tosh DK, Jacobson KA, Salvemini D. Chen Z, et al. FASEB J. 2012 May;26(5):1855-65. doi: 10.1096/fj.11-201541. Epub 2012 Feb 17. FASEB J. 2012. PMID: 22345405 Free PMC article. - Adenosine Receptors as Potential Therapeutic Analgesic Targets.
Haddad M, Cherchi F, Alsalem M, Al-Saraireh YM, Madae'en S. Haddad M, et al. Int J Mol Sci. 2023 Aug 24;24(17):13160. doi: 10.3390/ijms241713160. Int J Mol Sci. 2023. PMID: 37685963 Free PMC article. Review. - Neuroprotective Roles of the Adenosine A3 Receptor Agonist AST-004 in Mouse Model of Traumatic Brain Injury.
Bozdemir E, Vigil FA, Chun SH, Espinoza L, Bugay V, Khoury SM, Holstein DM, Stoja A, Lozano D, Tunca C, Sprague SM, Cavazos JE, Brenner R, Liston TE, Shapiro MS, Lechleiter JD. Bozdemir E, et al. Neurotherapeutics. 2021 Oct;18(4):2707-2721. doi: 10.1007/s13311-021-01113-7. Epub 2021 Oct 4. Neurotherapeutics. 2021. PMID: 34608616 Free PMC article. - Lack of adenosine A3 receptors causes defects in mouse peripheral blood parameters.
Hofer M, Pospíšil M, Dušek L, Hoferová Z, Komůrková D. Hofer M, et al. Purinergic Signal. 2014 Sep;10(3):509-14. doi: 10.1007/s11302-014-9412-9. Epub 2014 Apr 25. Purinergic Signal. 2014. PMID: 24763970 Free PMC article.
References
- Brand, A., Vissiennon, Z., Eschke, D., and Nieber, K. (2001). Adenosine A(1) and A(3) receptors mediate inhibition of synaptic transmission in rat cortical neurons. Neuropharmacology 40:85–95. - PubMed
- Cerniway, R. J., Yang, Z., Jacobson, M. A., Linden, J., and Matherne, G. P. (2001). Targeted deletion of A3 adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium. Am. J. Physiol. 281:H1751-H1758. - PubMed
- Di Iorio, P., Kleywegt, S., Ciccarelli, R., Traversa, U., Andrew, C. M., Crocker, C. E., Werstiuk, E. S., and Rathbone, M. P. (2002). Mechanisms of apoptosis induced by purine nucleosides in astrocytes. Glia 38:179. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous